Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Vox Sanguinis|October 17, 2022
Incidence and risk factors for graft failure in the modern era of cord blood transplantationJennifer Holter Chakrabarty, Joshua Glover, Sara Schmidt, et al.
Pharmaceutics|May 28, 2022
Nanotheranostics for Image-Guided Cancer TreatmentIsabel S Dennahy, Zheng Han, William M MacCuaig, et al.
Blood Advances|April 9, 2024
Distinguishing ASH clinical practice guidelines from other forms of ASH clinical adviceAdam Cuker, Robert Kunkle, Rachel S Bercovitz, et al.
The Lancet. Haematology|December 18, 2017
Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot studyKirsten M Williams, Jennifer Holter-Chakrabarty, Liza Lindenberg, et al.
Blood|September 4, 2015
Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infectionThomas H Price, Michael Boeckh, Ryan W Harrison, et al.
Blood|December 12, 2025
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trialEverett Meyer, Amandeep Salhotra, Arpita Gandhi, et al.
Transplantation and Cellular Therapy|July 7, 2023
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell LymphomaNarendranath Epperla, Ambuj Kumar, Syed A Abutalib, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2018
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice GuidelineJulie R Brahmer, Christina Lacchetti, Bryan J Schneider, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 17, 2020
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) EraSarah Schmidt, Ying Liu, Zhen-Huan Hu, et al.
Blood Advances|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTRKitsada Wudhikarn, Megan M Herr, Min Chen, et al.
Pageof 4